top of page

Sparian Biosciences

​

​

Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).

Press Release

NEW YORK, NY,  February 23, 2023 -- Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of First-In-Class Arylepoxamide Agonist, SBS-1000, for the Treatment of Pain ...

Home

AEAr Agonists

MOR Agonist/ DOR Antagonists

Irreversible MOR Antagonists

Peripheral DOR Bitopic Agonists

Sigma Antagonist/
DAT Inhibitors

Programs

bottom of page